Exact Sciences
M$872
254
+M$0+0% Wednesday 18:52
Statistik
Tag Hoch
872
Tag Tief
872
52W Hoch
1,660
52W Niedrig
760.88
Volumen
1,400
Durch. Volumen
73
Marktkap.
-
KGV
-
Dividendenrendite
-
Dividende
-
Demnächst
Gewinne
30OctErwartet
Erwartetes EPS
-3.8526196581
Tatsächliches EPS
K.A.
Leute folgen auch
Diese Liste basiert auf den Watchlists von Personen auf Stock Events, die EXAS.MX folgen. Es handelt sich nicht um eine Anlageempfehlung.
Wettbewerber
Diese Liste ist eine Analyse basierend auf aktuellen Marktereignissen. Es ist keine Anlageempfehlung.
Guardant Health
GH
Marktkap.3.15B
Illumina
ILMN
Marktkap.20.93B
Qiagen NV
QGEN
Marktkap.10.16B
Fulgent Genetics
FLGT
Marktkap.683.49M
Bio-Rad Laboratories
BIO
Marktkap.9.35B
Quest Diagnostics
DGX
Marktkap.17.47B
Labcorp
LH
Marktkap.19.3B
Pacific Biosciences of California
PACB
Marktkap.373.36M
Thermo Fisher Scientific
TMO
Marktkap.234.95B
Über
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Show more...
CEO
Mr. Kevin T. Conroy
Mitarbeiter
6300
Land
United States
ISIN
US30063P1057